Quantum BioPharma is trading 5.26% down now at $2.92 after announcing plans to voluntarily delist its Class B shares from the Canadian Securities Exchange.
- Nasdaq, Frankfurt, and Upstream listings remain active; September 4, 2026 is expected to be the final CSE trading day
- The announcement is the clearest company-specific development available, but no source quantifies its impact on today’s decline
- Broader markets and the biotech sector are moving higher, limiting macro explanations